
Company Number
10615484
Next Accounts
Dec 2025
Shareholders
john keep
imogen churchman
View AllGroup Structure
View All
Industry
Specialist medical practice activities
Registered Address
55 wessex street, norwich, NR2 2TJ
Website
n2surgical.co.ukPomanda estimates the enterprise value of NORWICH & NORFOLK SURGICAL LTD at £815.3k based on a Turnover of £1.7m and 0.47x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of NORWICH & NORFOLK SURGICAL LTD at £535.4k based on an EBITDA of £159.4k and a 3.36x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of NORWICH & NORFOLK SURGICAL LTD at £609.3k based on Net Assets of £303.6k and 2.01x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Norwich & Norfolk Surgical Ltd is a live company located in norwich, NR2 2TJ with a Companies House number of 10615484. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in February 2017, it's largest shareholder is john keep with a 12% stake. Norwich & Norfolk Surgical Ltd is a young, small sized company, Pomanda has estimated its turnover at £1.7m with healthy growth in recent years.
Pomanda's financial health check has awarded Norwich & Norfolk Surgical Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
3 Weak
Size
annual sales of £1.7m, make it larger than the average company (£488.2k)
- Norwich & Norfolk Surgical Ltd
£488.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (7.6%)
- Norwich & Norfolk Surgical Ltd
7.6% - Industry AVG
Production
with a gross margin of 52.8%, this company has a comparable cost of product (52.8%)
- Norwich & Norfolk Surgical Ltd
52.8% - Industry AVG
Profitability
an operating margin of 4.8% make it less profitable than the average company (14.7%)
- Norwich & Norfolk Surgical Ltd
14.7% - Industry AVG
Employees
with 22 employees, this is above the industry average (11)
22 - Norwich & Norfolk Surgical Ltd
11 - Industry AVG
Pay Structure
on an average salary of £30.5k, the company has an equivalent pay structure (£30.5k)
- Norwich & Norfolk Surgical Ltd
£30.5k - Industry AVG
Efficiency
resulting in sales per employee of £78.6k, this is equally as efficient (£72.7k)
- Norwich & Norfolk Surgical Ltd
£72.7k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is near the average (37 days)
- Norwich & Norfolk Surgical Ltd
37 days - Industry AVG
Creditor Days
its suppliers are paid after 122 days, this is slower than average (34 days)
- Norwich & Norfolk Surgical Ltd
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Norwich & Norfolk Surgical Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 37 weeks, this is less cash available to meet short term requirements (74 weeks)
37 weeks - Norwich & Norfolk Surgical Ltd
74 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 60.2%, this is a higher level of debt than the average (29.4%)
60.2% - Norwich & Norfolk Surgical Ltd
29.4% - Industry AVG
Norwich & Norfolk Surgical Ltd's latest turnover from March 2024 is estimated at £1.7 million and the company has net assets of £303.6 thousand. According to their latest financial statements, Norwich & Norfolk Surgical Ltd has 22 employees and maintains cash reserves of £334.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 22 | 19 | 9 | 9 | 11 | ||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 204,895 | 153,565 | 192,420 | 125,710 | 47,697 | ||
Intangible Assets | 4,474 | 5,966 | |||||
Investments & Other | |||||||
Debtors (Due After 1 year) | |||||||
Total Fixed Assets | 209,369 | 159,531 | 192,420 | 125,710 | 47,697 | ||
Stock & work in progress | |||||||
Trade Debtors | 201,541 | 208,643 | 145,101 | 186,952 | 121,211 | 201,429 | 178,746 |
Group Debtors | |||||||
Misc Debtors | 16,774 | 11,557 | 14,478 | 397 | 2 | 2 | |
Cash | 334,226 | 189,932 | 351,535 | 128,908 | 278,361 | 124,610 | 189,272 |
misc current assets | |||||||
total current assets | 552,541 | 410,132 | 511,114 | 316,257 | 399,574 | 326,041 | 368,018 |
total assets | 761,910 | 569,663 | 703,534 | 441,967 | 447,271 | 326,041 | 368,018 |
Bank overdraft | |||||||
Bank loan | |||||||
Trade Creditors | 273,948 | 258,159 | 370,212 | 253,405 | 84,345 | 137,651 | 114,251 |
Group/Directors Accounts | |||||||
other short term finances | |||||||
hp & lease commitments | |||||||
other current liabilities | 184,384 | 80,364 | 101,625 | 43,189 | 138,843 | 112,237 | 181,523 |
total current liabilities | 458,332 | 338,523 | 471,837 | 296,594 | 223,188 | 249,888 | 295,774 |
loans | |||||||
hp & lease commitments | |||||||
Accruals and Deferred Income | |||||||
other liabilities | |||||||
provisions | |||||||
total long term liabilities | |||||||
total liabilities | 458,332 | 338,523 | 471,837 | 296,594 | 223,188 | 249,888 | 295,774 |
net assets | 303,578 | 231,140 | 231,697 | 145,373 | 224,083 | 76,153 | 72,244 |
total shareholders funds | 303,578 | 231,140 | 231,697 | 145,373 | 224,083 | 76,153 | 72,244 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 75,038 | 51,775 | 40,789 | 16,574 | 1,539 | ||
Amortisation | 1,492 | 1,492 | |||||
Tax | |||||||
Stock | |||||||
Debtors | -1,885 | 60,621 | -27,770 | 66,136 | -80,218 | 22,685 | 178,746 |
Creditors | 15,789 | -112,053 | 116,807 | 169,060 | -53,306 | 23,400 | 114,251 |
Accruals and Deferred Income | 104,020 | -21,261 | 58,436 | -95,654 | 26,606 | -69,286 | 181,523 |
Deferred Taxes & Provisions | |||||||
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | |||||||
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | |||||||
Group/Directors Accounts | |||||||
Other Short Term Loans | |||||||
Long term loans | |||||||
Hire Purchase and Lease Commitments | |||||||
other long term liabilities | |||||||
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 144,294 | -161,603 | 222,627 | -149,453 | 153,751 | -64,662 | 189,272 |
overdraft | |||||||
change in cash | 144,294 | -161,603 | 222,627 | -149,453 | 153,751 | -64,662 | 189,272 |
Perform a competitor analysis for norwich & norfolk surgical ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in NR2 area or any other competitors across 12 key performance metrics.
NORWICH & NORFOLK SURGICAL LTD group structure
Norwich & Norfolk Surgical Ltd has no subsidiary companies.
Ultimate parent company
NORWICH & NORFOLK SURGICAL LTD
10615484
Norwich & Norfolk Surgical Ltd currently has 9 directors. The longest serving directors include Dr Jeanine Smirl (Feb 2017) and Dr John Keep (Apr 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Jeanine Smirl | England | 61 years | Feb 2017 | - | Director |
Dr John Keep | United Kingdom | 44 years | Apr 2017 | - | Director |
Dr Thomas Casey | United Kingdom | 38 years | Apr 2017 | - | Director |
Dr Imogen Churchman | United Kingdom | 57 years | Apr 2017 | - | Director |
Dr Timothy Bosworth | United Kingdom | 58 years | Oct 2017 | - | Director |
Dr Alexandra Baker | United Kingdom | 37 years | Oct 2019 | - | Director |
Mr James Foster | 56 years | Oct 2019 | - | Director | |
Dr Melissa Korn | United Kingdom | 59 years | Oct 2021 | - | Director |
Dr James Courtenay | United Kingdom | 36 years | Oct 2021 | - | Director |
P&L
March 2024turnover
1.7m
+1%
operating profit
82.8k
0%
gross margin
52.9%
-1.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
303.6k
+0.31%
total assets
761.9k
+0.34%
cash
334.2k
+0.76%
net assets
Total assets minus all liabilities
company number
10615484
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
February 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
55 wessex street, norwich, NR2 2TJ
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to norwich & norfolk surgical ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NORWICH & NORFOLK SURGICAL LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|